Literature DB >> 2509886

Eosinophilia-myalgia syndrome--New Mexico.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2509886

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


× No keyword cloud information.
  8 in total

1.  Investigations of selected historically important syndromic outbreaks: impact and lessons learned for public health preparedness and response.

Authors:  Richard A Goodman; Joseph M Posid; Tanja Popovic
Journal:  Am J Public Health       Date:  2012-02-16       Impact factor: 9.308

2.  Eosinophilia, myopathy, and neuropathy in a patient with repeated use of L-tryptophan.

Authors:  J J Goronzy; C M Weyand
Journal:  Klin Wochenschr       Date:  1990-07-17

Review 3.  Tryptophan. Current status and future trends for oral administration.

Authors:  L D Kaufman; R M Philen
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

4.  Eosinophilia-myalgia syndrome: selective cognitive impairment, longitudinal effects, and neuroimaging findings.

Authors:  C Armstrong; T Lewis; M D'Esposito; B Freundlich
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

5.  Chronic fatigue: a peculiar evolution of eosinophilia myalgia syndrome following treatment with L-tryptophan in four Italian adolescents.

Authors:  R Priori; F Conti; F L Luan; C Arpino; G Valesini
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

6.  Contaminants in L-tryptophan associated with eosinophilia myalgia syndrome.

Authors:  R H Hill; S P Caudill; R M Philen; S L Bailey; W D Flanders; W J Driskell; M L Kamb; L L Needham; E J Sampson
Journal:  Arch Environ Contam Toxicol       Date:  1993-07       Impact factor: 2.804

7.  1,1'-Ethylidenebis(tryptophan) (Peak E) induces functional activation of human eosinophils and interleukin 5 production from T lymphocytes: association of eosinophilia-myalgia syndrome with a L-tryptophan contaminant.

Authors:  K A Yamaoka; N Miyasaka; G Inuo; I Saito; J P Kolb; K Fujita; S Kashiwazaki
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

8.  Accumulation of 1-methyl-tetrahydro-beta-carboline-3-carboxylic acid in blood and organs of rat. A possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.

Authors:  Y Ogawa; J Adachi; Y Tatsuno
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.